Affinity Asset Advisors, LLC - 20 May 2025 SCHEDULE 13G/A Report for Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share (INZY)

Filing Manager
Affinity Asset Advisors, LLC
Reporting Manager
Affinity Healthcare Fund, LP
Security
Inozyme Pharma, Inc. Common Stock, par value $0.0001 per share
Symbol
INZY
Shares outstanding
64,626,644 shares
Disclosed Ownership
1,867,710 shares
Ownership
2.89%
Form type
SCHEDULE 13G/A
Filing time
30 May 2025, 17:24:02 UTC
Date of event
20 May 2025
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Affinity Healthcare Fund, LP 2.89% 1,867,710 0 1,867,710 /s/ Andrew Weinstein Andrew Weinstein
Affinity Asset Advisors, LLC 2.89% 1,867,710 0 1,867,710 /s/ Andrew Weinstein Andrew Weinstein